Pennings E J M, Opperhuizen A, van Amsterdam J G C
Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands.
Regul Toxicol Pharmacol. 2008 Dec;52(3):199-207. doi: 10.1016/j.yrtph.2008.08.005. Epub 2008 Aug 22.
In preparing a decision about the legal status of khat in the Netherlands, the Dutch Minister of Health requested CAM (Coordination point Assessment and Monitoring new drugs) to assess the overall risk of khat in the Netherlands. The present paper is a redraft of a report which formed the scientific basis of the risk evaluation procedure (October 2007). This report reviews the scientific data about khat available in the international literature. In addition, the report contains some information specific for the Netherlands (prevalence, availability of khat and public order aspects). The main psychoactive compounds in khat leaves are cathine and cathinone, which are some 2- to 10-fold less active than amphetamine. Acute health problems are rarely seen, and are usually related with malnutrition, social and financial problems. Khat has a low addictive potential. Chronic toxicity of khat is modest when used in low amounts, whereas at high levels, khat use is associated with adverse effects, like hypertension, heart rhythm disorders, insomnia and loss of appetite. In addition, khat users show a higher prevalence of cancers in the digestive tract. At population level, khat does not lead to specific health risks in the Netherlands, as its use is confined to East-African immigrants. A relationship between khat use and psychiatric disorders has been suggested, but the reports are contradictory, and such studies are presumably heavily confounded by posttraumatic and social stress. In the Netherlands (and other countries), khat use occasionally leads to minor disturbance of civil order in the public domain (loud talking, spitting), but is not related to criminal activities. Following the assessment, CAM estimated the overall risk potential of khat use in the Netherlands as very low. A similar conclusion may be drawn for countries with a comparable prevalence of khat use and khat related public order disturbance.
在就巧茶在荷兰的法律地位做出决定时,荷兰卫生部长要求药品评估与监测协调中心(CAM)评估巧茶在荷兰的总体风险。本文是一份报告的重新起草版本,该报告构成了风险评估程序的科学基础(2007年10月)。本报告回顾了国际文献中有关巧茶的科学数据。此外,报告还包含了一些荷兰特有的信息(流行情况、巧茶的可得性以及公共秩序方面)。巧茶叶中的主要精神活性成分是去甲伪麻黄碱和卡西酮,其活性约为苯丙胺的2至10倍。急性健康问题很少见,通常与营养不良、社会和经济问题有关。巧茶的成瘾潜力较低。少量使用巧茶时,其慢性毒性较小,而大量使用时,巧茶的使用与高血压、心律紊乱、失眠和食欲不振等不良反应有关。此外,巧茶使用者消化道癌症的患病率较高。在荷兰的人群层面,巧茶的使用并未导致特定的健康风险,因为其使用仅限于东非移民。有人提出巧茶的使用与精神障碍之间存在关联,但报告相互矛盾,而且此类研究可能受到创伤后应激和社会压力的严重混淆。在荷兰(以及其他国家),巧茶的使用偶尔会在公共场所导致轻微的公共秩序干扰(大声喧哗、随地吐痰),但与犯罪活动无关。经过评估,CAM估计在荷兰使用巧茶的总体潜在风险非常低。对于巧茶使用流行率和与巧茶相关的公共秩序干扰情况相当的国家,可能会得出类似的结论。